» Articles » PMID: 3026637

Retrovirus Antigens Recognized by Cytolytic T Lymphocytes Activate Tumor Rejection in Vivo

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1987 Jan 30
PMID 3026637
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

We have initiated the molecular definition of the antigens recognized by Gross MuLV-specific cytolytic T lymphocytes on the surface of Gross MuLV-induced tumor cells. A panel of target cells was obtained by the double transfection and expression of a retrovirus gene and a foreign H-2 gene in recipient mouse fibroblasts. Our results show that class I H-2 transplantation antigens have a directive influence in determining the antigenicity of proteins encoded by the gag and env MuLV genes. Genes not linked to H-2 influence the intensity and the specificity of the cytolytic T lymphocyte response to Gross MuLV-induced tumors. Finally, MuLV-induced antigens expressed by transfected fibroblasts induce tumor immunity and lead to accelerated tumor rejection in vivo.

Citing Articles

Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy.

Gong P, Wang Y, Zhang P, Yang Z, Deng W, Sun Z Cancers (Basel). 2021; 13(1).

PMID: 33396603 PMC: 7794746. DOI: 10.3390/cancers13010077.


Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus).

Kazanji M, Tartaglia J, Franchini G, de Thoisy B, Talarmin A, Contamin H J Virol. 2001; 75(13):5939-48.

PMID: 11390595 PMC: 114309. DOI: 10.1128/JVI.75.13.5939-5948.2001.


Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia.

Yotnda P, Firat H, Garcia Z, Gourru G, Vernant J, Lemonnier F J Clin Invest. 1998; 101(10):2290-6.

PMID: 9593785 PMC: 508817. DOI: 10.1172/JCI488.


Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.

Ossendorp F, Mengede E, Camps M, Filius R, Melief C J Exp Med. 1998; 187(5):693-702.

PMID: 9480979 PMC: 2212165. DOI: 10.1084/jem.187.5.693.


Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.

Kurokohchi K, Akatsuka T, Pendleton C, Takamizawa A, Nishioka M, Battegay M J Virol. 1996; 70(1):232-40.

PMID: 8523531 PMC: 189809. DOI: 10.1128/JVI.70.1.232-240.1996.